The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Intravenous General Anesthetics Market Research Report 2024

Global Intravenous General Anesthetics Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1744080

No of Pages : 101

Ask Your Query

Synopsis
Intravenous anesthesia is administered through a vein to provide general anesthesia.

Global Intravenous General Anesthetics market is projected to reach US$ 7160.9 million in 2029, increasing from US$ 5560 million in 2022, with the CAGR of 3.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous General Anesthetics market research.

Key manufacturers engaged in the Intravenous General Anesthetics industry include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B. Braun Melsungen, Liaoning Haisco, Pfizer, Teva Pharmaceutical Industries and Fresenius Kabi AG, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Intravenous General Anesthetics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous General Anesthetics market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intravenous General Anesthetics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • AstraZeneca
  • Fresenius-Kabi
  • AbbVie
  • Baxter Healthcare
  • B. Braun Melsungen
  • Liaoning Haisco
  • Pfizer
  • Teva Pharmaceutical Industries
  • Fresenius Kabi AG
  • SGPharma
  • Jiangsu Nhua Pharmaceutical Co., Ltd.
  • Xi'an Libang Pharmaceutical Co., Ltd.
  • Baxter international
  • Sichuan Guorui Pharmaceutical Co., Ltd.
  • Hikma

Segment by Type

  • Sedative
  • Analgesics
  • Muscle Relaxants

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Intravenous General Anesthetics report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Intravenous General Anesthetics Market Overview
1.1 Product Overview and Scope of Intravenous General Anesthetics
1.2 Intravenous General Anesthetics Segment by Type
1.2.1 Global Intravenous General Anesthetics Market Value Comparison by Type (2023-2029)
1.2.2 Sedative
1.2.3 Analgesics
1.2.4 Muscle Relaxants
1.3 Intravenous General Anesthetics Segment by Application
1.3.1 Global Intravenous General Anesthetics Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Intravenous General Anesthetics Market Size Estimates and Forecasts
1.4.1 Global Intravenous General Anesthetics Revenue 2018-2029
1.4.2 Global Intravenous General Anesthetics Sales 2018-2029
1.4.3 Global Intravenous General Anesthetics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intravenous General Anesthetics Market Competition by Manufacturers
2.1 Global Intravenous General Anesthetics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intravenous General Anesthetics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intravenous General Anesthetics Average Price by Manufacturers (2018-2023)
2.4 Global Intravenous General Anesthetics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intravenous General Anesthetics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous General Anesthetics, Product Type & Application
2.7 Intravenous General Anesthetics Market Competitive Situation and Trends
2.7.1 Intravenous General Anesthetics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous General Anesthetics Players Market Share by Revenue
2.7.3 Global Intravenous General Anesthetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous General Anesthetics Retrospective Market Scenario by Region
3.1 Global Intravenous General Anesthetics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intravenous General Anesthetics Global Intravenous General Anesthetics Sales by Region: 2018-2029
3.2.1 Global Intravenous General Anesthetics Sales by Region: 2018-2023
3.2.2 Global Intravenous General Anesthetics Sales by Region: 2024-2029
3.3 Global Intravenous General Anesthetics Global Intravenous General Anesthetics Revenue by Region: 2018-2029
3.3.1 Global Intravenous General Anesthetics Revenue by Region: 2018-2023
3.3.2 Global Intravenous General Anesthetics Revenue by Region: 2024-2029
3.4 North America Intravenous General Anesthetics Market Facts & Figures by Country
3.4.1 North America Intravenous General Anesthetics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intravenous General Anesthetics Sales by Country (2018-2029)
3.4.3 North America Intravenous General Anesthetics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous General Anesthetics Market Facts & Figures by Country
3.5.1 Europe Intravenous General Anesthetics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intravenous General Anesthetics Sales by Country (2018-2029)
3.5.3 Europe Intravenous General Anesthetics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous General Anesthetics Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous General Anesthetics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intravenous General Anesthetics Sales by Country (2018-2029)
3.6.3 Asia Pacific Intravenous General Anesthetics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intravenous General Anesthetics Market Facts & Figures by Country
3.7.1 Latin America Intravenous General Anesthetics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intravenous General Anesthetics Sales by Country (2018-2029)
3.7.3 Latin America Intravenous General Anesthetics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intravenous General Anesthetics Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous General Anesthetics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intravenous General Anesthetics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intravenous General Anesthetics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous General Anesthetics Sales by Type (2018-2029)
4.1.1 Global Intravenous General Anesthetics Sales by Type (2018-2023)
4.1.2 Global Intravenous General Anesthetics Sales by Type (2024-2029)
4.1.3 Global Intravenous General Anesthetics Sales Market Share by Type (2018-2029)
4.2 Global Intravenous General Anesthetics Revenue by Type (2018-2029)
4.2.1 Global Intravenous General Anesthetics Revenue by Type (2018-2023)
4.2.2 Global Intravenous General Anesthetics Revenue by Type (2024-2029)
4.2.3 Global Intravenous General Anesthetics Revenue Market Share by Type (2018-2029)
4.3 Global Intravenous General Anesthetics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intravenous General Anesthetics Sales by Application (2018-2029)
5.1.1 Global Intravenous General Anesthetics Sales by Application (2018-2023)
5.1.2 Global Intravenous General Anesthetics Sales by Application (2024-2029)
5.1.3 Global Intravenous General Anesthetics Sales Market Share by Application (2018-2029)
5.2 Global Intravenous General Anesthetics Revenue by Application (2018-2029)
5.2.1 Global Intravenous General Anesthetics Revenue by Application (2018-2023)
5.2.2 Global Intravenous General Anesthetics Revenue by Application (2024-2029)
5.2.3 Global Intravenous General Anesthetics Revenue Market Share by Application (2018-2029)
5.3 Global Intravenous General Anesthetics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Intravenous General Anesthetics Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Corporation Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Fresenius-Kabi Intravenous General Anesthetics Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AbbVie Intravenous General Anesthetics Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Corporation Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter Healthcare Intravenous General Anesthetics Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Corporation Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Melsungen Intravenous General Anesthetics Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 Liaoning Haisco
6.6.1 Liaoning Haisco Corporation Information
6.6.2 Liaoning Haisco Description and Business Overview
6.6.3 Liaoning Haisco Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Liaoning Haisco Intravenous General Anesthetics Product Portfolio
6.6.5 Liaoning Haisco Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Intravenous General Anesthetics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical Industries
6.8.1 Teva Pharmaceutical Industries Corporation Information
6.8.2 Teva Pharmaceutical Industries Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceutical Industries Intravenous General Anesthetics Product Portfolio
6.8.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.9 Fresenius Kabi AG
6.9.1 Fresenius Kabi AG Corporation Information
6.9.2 Fresenius Kabi AG Description and Business Overview
6.9.3 Fresenius Kabi AG Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Fresenius Kabi AG Intravenous General Anesthetics Product Portfolio
6.9.5 Fresenius Kabi AG Recent Developments/Updates
6.10 SGPharma
6.10.1 SGPharma Corporation Information
6.10.2 SGPharma Description and Business Overview
6.10.3 SGPharma Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SGPharma Intravenous General Anesthetics Product Portfolio
6.10.5 SGPharma Recent Developments/Updates
6.11 Jiangsu Nhua Pharmaceutical Co., Ltd.
6.11.1 Jiangsu Nhua Pharmaceutical Co., Ltd. Corporation Information
6.11.2 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Description and Business Overview
6.11.3 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product Portfolio
6.11.5 Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Xi'an Libang Pharmaceutical Co., Ltd.
6.12.1 Xi'an Libang Pharmaceutical Co., Ltd. Corporation Information
6.12.2 Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Description and Business Overview
6.12.3 Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product Portfolio
6.12.5 Xi'an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Baxter international
6.13.1 Baxter international Corporation Information
6.13.2 Baxter international Intravenous General Anesthetics Description and Business Overview
6.13.3 Baxter international Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Baxter international Intravenous General Anesthetics Product Portfolio
6.13.5 Baxter international Recent Developments/Updates
6.14 Sichuan Guorui Pharmaceutical Co., Ltd.
6.14.1 Sichuan Guorui Pharmaceutical Co., Ltd. Corporation Information
6.14.2 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Description and Business Overview
6.14.3 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product Portfolio
6.14.5 Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Hikma
6.15.1 Hikma Corporation Information
6.15.2 Hikma Intravenous General Anesthetics Description and Business Overview
6.15.3 Hikma Intravenous General Anesthetics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Hikma Intravenous General Anesthetics Product Portfolio
6.15.5 Hikma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous General Anesthetics Industry Chain Analysis
7.2 Intravenous General Anesthetics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous General Anesthetics Production Mode & Process
7.4 Intravenous General Anesthetics Sales and Marketing
7.4.1 Intravenous General Anesthetics Sales Channels
7.4.2 Intravenous General Anesthetics Distributors
7.5 Intravenous General Anesthetics Customers
8 Intravenous General Anesthetics Market Dynamics
8.1 Intravenous General Anesthetics Industry Trends
8.2 Intravenous General Anesthetics Market Drivers
8.3 Intravenous General Anesthetics Market Challenges
8.4 Intravenous General Anesthetics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock